Q3 earnings beat estimates, but shares dip as 2025 sales outlook narrows. Get key highlights and pharma market insights.

Merck boosts its full-year outlook as third-quarter earnings top estimates following strong demand for its blockbuster cancer ...

Merck shares dipped after strong earnings and higher profit guidance, as the company narrowed its 2025 sales forecast amid ...

Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.

Discover Merck & Co., Inc.'s Q3 earnings outlook as Keytruda's patent nears expiry. Click for my updated look at MRK stock ...

Global pharmaceutical company Merck (NYSE:MRK) will be reporting earnings this Thursday morning. Here’s what you need to know ...

Johnson & Johnson JNJ and MerckMRK are leading U.S. healthcare giants, making them natural peers for a head-to-head ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over the ...

Investing.com - Merck&Co (NYSE: MRK) reported third quarter EPS of $2.58, $0.23 better than the analyst estimate of $2.35. Revenue for the quarter came in at $17.28B versus the consensus estimate of ...